Zweig Di Menna Associates LLC Soma Logic, Inc. Transaction History

Zweig Di Menna Associates LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$1.76 - $2.83 $70,400 - $113,200	-40,000 Reduced 6.37%	588,218 $1.49 Million
Q3 2023 Oct 25, 2023	SELL	$1.99 - $2.45 $477,600 - $588,000	-240,000 Reduced 27.64%	628,218 $1.5 Million
Q2 2023 Jul 26, 2023	SELL	$2.1 - $3.36 $840,000 - $1.34 Million	-400,000 Reduced 31.54%	868,218 $2.01 Million
Q1 2023 Apr 28, 2023	SELL	$2.13 - $3.6 $260,925 - $441,000	-122,500 Reduced 8.81%	1,268,218 $3.23 Million
Q4 2022 Feb 07, 2023	BUY	$2.05 - $3.47 $57,399 - $97,160	28,000 Added 2.05%	1,390,718 $3.49 Million
Q3 2022 Oct 28, 2022	BUY	$0.63 - $5.47 $24,707 - $214,522	39,218 Added 2.96%	1,362,718 $3.95 Million
Q2 2022 Jul 28, 2022	BUY	$4.27 - $8.26 $742,552 - $1.44 Million	173,900 Added 15.13%	1,323,500 $5.98 Million
Q1 2022 Apr 25, 2022	BUY	$7.07 - $11.62 $813,050 - $1.34 Million	115,000 Added 11.12%	1,149,600 $9.22 Million
Q4 2021 Jan 27, 2022	BUY	$10.49 - $14.28 $7.64 Million - $10.4 Million	728,110 Added 237.56%	1,034,600 $12 Million
Q3 2021 Oct 25, 2021	BUY	$9.94 - $12.77 $3.05 Million - $3.91 Million	306,490 New	306,490 $3.8 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Zweig Di Menna Associates LLC with notifications on news.